ME/CFS Science @mecfsscience.org · 27/07/20263) The trial also focuses on a very specific subset of ME/CFS patients with elevated antibodies against β2-adrenergic receptors and "a pro-inflammatory immune cell status." 181
ME/CFS Science @mecfsscience.org · 27/07/20264) In addition, the patients must have received immunoadsorption in a previous trial. The must have had an initial positive response to the immunonadsorption followed by a worsening afterwards. Such a pattern suggest that there was a positive effect but it wasn't sustained. 181
ME/CFS Science @mecfsscience.org · 27/07/20265) Participants must have PAIS (so post-infectious) and meet the Canadian criteria for ME/CFS, including post-exertional malaise lasting more than 14 hours. The primary outcome for the trial is the SF-36 subscale for physical functioning. 190
